Anti-tumorigenic properties by trichothiodystrophy mutations in melanocytic cells
NAR Cancer · 2025
DOI: 10.1093/narcan/zcaf026 ↗Kurz gefasst
Fachartikel in der Zeitschrift NAR Cancer, 2025. Verfasst von Rupesh Paudel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany. Hauptthemen laut MEDLINE: Melanocytes, Trichothiodystrophy Syndromes, Melanoma, Xeroderma Pigmentosum Group D Protein. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Graduate School of Life Sciences, German Cancer Aid, Monika Kutzner Foundation.
Abstract (Originalsprache)
Germline mutations in the DNA repair helicase XPD can cause the diseases xeroderma pigmentosum (XP) and trichothiodystrophy (TTD). XP patients bear an increased risk of skin cancer including melanoma. This is not observed for TTD patients despite DNA repair defects. To examine whether TTD cells harbor features counteracting tumorigenesis, we developed a TTD melanoma cell model containing the XPD variant R722W. Intriguingly, TTD melanoma cells exhibited reduced proliferation and an increased signature of the melanocyte lineage factor MITF, along with a strong basal upregulation of REDD2, an inhibitor of the mTOR/S6K/4EBP1-dependent messenger RNA (mRNA) translation machinery. REDD2 levels were partially driven by MITF and contributed to reduced melanoma proliferation. In a TTD model for melanocytes—the progenitor cells of melanoma—the MITF gene signature was also increased, but here without affecting REDD2 expression. However, ribosomal protein synthesis was reduced particularly in R722W melanocytes after UV stress, indicating a compromised mRNA translation machinery. Impaired translation was also demonstrated for the TTD XPD variant A725P, but not for an XP variant. Concludingly, the impaired translation and reduced fitness observed in TTD melanocytes and melanoma cells, particularly after UV stress, offer a possible explanation why TTD patients do not develop melanomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany.
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, 97080Würzburg, Germany.
- Rudolf Virchow Center for Integrative and Translational Bioimaging, Institute for Structural Biology, University of Würzburg, 97080 Würzburg, Germany.
- Klinikum Stuttgart, 70174 Stuttgart, Germany.
- Department of Biochemistry and Cell Biology, University of Würzburg, 97074 Würzburg, Germany.
- Rudolf Virchow Center for Integrative and Translational Bioimaging, Mass Spectrometry Division, University of Würzburg, 97080 Würzburg, Germany.
ORCID-Profile: Caroline Kisker, Jochen Kuper, Svenja Meierjohann
Förderung
- Graduate School of Life Sciences
- German Cancer Aid
- Monika Kutzner Foundation
- Brigitte and Dr Konstanze Wegener Foundation
Zitieren
APA
Paudel, R., Sorger, L. F., Hufnagel, A., Pasemann, M., Hove, T., Marquardt, A., Kneitz, S., Schlosser, A., Kisker, C., Kuper, J., & Meierjohann, S. (2025). Anti-tumorigenic properties by trichothiodystrophy mutations in melanocytic cells. NAR Cancer. https://doi.org/10.1093/narcan/zcaf026
Vancouver
Paudel R, Sorger LF, Hufnagel A, Pasemann M, Hove T, Marquardt A, et al. Anti-tumorigenic properties by trichothiodystrophy mutations in melanocytic cells. NAR Cancer. 2025. doi:10.1093/narcan/zcaf026
BibTeX
@article{Paudel2025,
author = {Paudel, Rupesh and Sorger, Lena F and Hufnagel, Anita and Pasemann, Mira and Hove, Tamsanqa and Marquardt, André and Kneitz, Susanne and Schlosser, Andreas and Kisker, Caroline and Kuper, Jochen and Meierjohann, Svenja},
title = {Anti-tumorigenic properties by trichothiodystrophy mutations in melanocytic cells},
journal = {NAR Cancer},
year = {2025},
doi = {10.1093/narcan/zcaf026}
}
EUVIMED